These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12430251)

  • 1. [Ischemic heart disease in diabetes].
    Horiuchi H; Kita T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():342-6. PubMed ID: 12430251
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetes mellitus and ischemic heart diseases].
    Yamada N
    Nihon Rinsho; 2003 May; 61 Suppl 5():884-7. PubMed ID: 12809050
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors and primary prevention of ischemic heart disease in women.
    Abramson B
    Can J Cardiol; 2001 Nov; 17 Suppl D():24D-31D. PubMed ID: 11726993
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipidemia in patients with ischemic heart disease].
    Murase T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():722-7. PubMed ID: 11347161
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of ischemic heart disease in women.
    Lonn E
    Can J Cardiol; 2001 Nov; 17 Suppl D():14D-23D. PubMed ID: 11726992
    [No Abstract]   [Full Text] [Related]  

  • 6. [The risk factors for ischemic heart disease in young adults].
    Tomono S; Ohshima S; Kawazu S
    Nihon Rinsho; 1994 Aug; 52 Suppl(Pt 2):40-6. PubMed ID: 12439949
    [No Abstract]   [Full Text] [Related]  

  • 7. [Risk factors for ischemic heart disease in young adults].
    Kobayashi T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():753-6. PubMed ID: 12735061
    [No Abstract]   [Full Text] [Related]  

  • 8. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G
    Orv Hetil; 1999 Jul; 140(28):1563-72. PubMed ID: 10443132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta blockers, fibrinogen, and atherosclerosis].
    Serrano Aguilar PG
    Med Clin (Barc); 1994 Feb; 102(6):231-5. PubMed ID: 7909001
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypertension in patients with ischemic heart disease].
    Furukawa Y; Kimura T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():465-70. PubMed ID: 15171417
    [No Abstract]   [Full Text] [Related]  

  • 11. Ischemic heart disease in women: an appropriate time to discriminate.
    Tremmel JA; Yeung AC
    Rev Cardiovasc Med; 2007; 8(2):61-8. PubMed ID: 17603424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ischemic heart disease should have causal treatment].
    Fedorowski JJ; Pasyk S
    Kardiol Pol; 1993 Jun; 38(6):453-5. PubMed ID: 8366660
    [No Abstract]   [Full Text] [Related]  

  • 13. [The myocardial revascularization in patients with diabetes mellitus and the ischemic heart disease].
    Chvokov AV
    Khirurgiia (Mosk); 2012; (4):55-8. PubMed ID: 22833895
    [No Abstract]   [Full Text] [Related]  

  • 14. Gingivitis in the genesis of heart attack and other arteriosclerotic diseases.
    Wehrmacher WH
    Dent Today; 2001 Nov; 20(11):94-5. PubMed ID: 11715659
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal impairment: a risk factor for ischemic heart disease.
    Zoccali C
    Curr Opin Pharmacol; 2006 Apr; 6(2):221-5. PubMed ID: 16483843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Should individuals without evidence of coronary disease and with risk factors receive continuous treatment with aspirin? Arguments in favor].
    Calvo F; Barrabés JA; García-Dorado D
    Rev Esp Cardiol; 1996 Nov; 49(11):793-800. PubMed ID: 9082488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention program for ischemic heart disease].
    Okada K; Fujimoto K; Izumi T; Konishi M
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():768-74. PubMed ID: 12735064
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperlipidemia and primary prevention of ischemic heart disease].
    Gérvas J; Pérez Fernández M
    Med Clin (Barc); 1997 Oct; 109(14):549-52. PubMed ID: 9508617
    [No Abstract]   [Full Text] [Related]  

  • 19. Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes.
    Barthelemy O; Jacqueminet S; Rouzet F; Isnard R; Bouzamondo A; Le Guludec D; Grimaldi A; Metzger JP; Le Feuvre C
    Arch Cardiovasc Dis; 2008 Sep; 101(9):539-46. PubMed ID: 19041838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.